{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T04:55:25Z","timestamp":1774500925531,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000325","name":"Wellbeing of Women","doi-asserted-by":"publisher","award":["RG1357"],"award-info":[{"award-number":["RG1357"]}],"id":[{"id":"10.13039\/501100000325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The female climacteric or menopausal process characterised by reduced estrogen, associates with an increased risk of recurrent urinary tract infections (rUTIs) linked to uropathogenic <jats:italic>Escherichia coli<\/jats:italic> (UPEC). Clinically, topical vaginal estrogen treatment has a prophylactic effect against such infections. The aim of this study was to investigate, <jats:italic>in vitro<\/jats:italic>, the effects of a topical estrogen treatment on vaginal epithelial responses following challenge with <jats:italic>E.coli<\/jats:italic> flagellin mimicking an UPEC challenge. Immortalised vaginal epithelial cells (VK2 E6\/E7), modelling the vaginal epithelium were treated with either 4\u2009nM 17\u03b2-estradiol (E) for seven days, 50\u2009ng\/ml <jats:italic>E.coli<\/jats:italic> flagellin (F) for 12\u2009h, or 4\u2009nM 17\u03b2-estradiol plus 50\u2009ng\/ml flagellin (E\u2009+\u2009F(12\u2009h)). RNA was analysed by microarray gene profiling using the Illumina HumanHT-12 v 4 Expression Beadchip. Following E\u2009+\u2009F treatments expression of genes encoding host defence molecules including <jats:italic>DEF\u03b24A<\/jats:italic>, <jats:italic>DEFB103A<\/jats:italic>, <jats:italic>LCN2<\/jats:italic> as well as those associated with keratinisation eg <jats:italic>CNFN<\/jats:italic> and <jats:italic>SPRR<\/jats:italic> family genes were significantly enhanced (P\u2009&lt;\u20090.05) compared to either E or F treatments alone. Mutation of estrogen responsive elements (EREs) identified in the <jats:italic>DEF\u03b24<\/jats:italic> gene promoter abolished the augmented gene expression suggesting estrogen functioned directly through a regulatory mechanism involving ESR1\/2. Ingenuity pathway analyses also suggested the pro-inflammatory cytokine IL-17A to regulate the vaginal host defences during infection. Pre-treating VK2 E6\/E7 cells with estrogen (4\u2009nM) and challenging with 1L-17A &amp; F (12\u2009h) significantly enhanced <jats:italic>DEF\u03b24, DEF103A<\/jats:italic> and <jats:italic>S100A7<\/jats:italic> expression (P\u2009&lt;\u20090.05). Origins of vaginal IL-17 <jats:italic>in vivo<\/jats:italic> remain unclear, but patient biopsies support \u03b3\u03b4 T cells located within the vaginal epithelium. These data suggest that the vaginal antimicrobial response induced by flagellin activation of Toll-like Receptor 5 cell signalling is augmented following topical estrogen application.<\/jats:p>","DOI":"10.1038\/s41598-020-64291-y","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T10:02:26Z","timestamp":1590055346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Topical Estrogen Treatment Augments the Vaginal Response to Escherichia coli Flagellin"],"prefix":"10.1038","volume":"10","author":[{"given":"Anna","family":"Stanton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8234-0276","authenticated-orcid":false,"given":"Catherine","family":"Mowbray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Lanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2541-5195","authenticated-orcid":false,"given":"Paul","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Tyson-Capper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Pickard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ased S. M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,21]]},"reference":[{"key":"64291_CR1","doi-asserted-by":"crossref","unstructured":"Perrotta, C., Aznar, M., Mejia, R., Albert, X. & Ng, C.W. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. The Cochrane database of systematic reviews, CD005131 (2008).","DOI":"10.1002\/14651858.CD005131.pub2"},{"key":"64291_CR2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/AOG.0b013e318185f7a5","volume":"112","author":"C Perrotta","year":"2008","unstructured":"Perrotta, C., Aznar, M., Mejia, R., Albert, X. & Ng, C. W. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Obstetrics and gynecology 112, 689\u2013690 (2008).","journal-title":"Obstetrics and gynecology"},{"key":"64291_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles, A. L., Walker, J. N., Caparon, M. & Hultgren, S. J. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature reviews Microbiology 13, 269\u2013284 (2015).","journal-title":"Nature reviews Microbiology"},{"key":"64291_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/0090-4295(85)90458-3","volume":"25","author":"AS Cass","year":"1985","unstructured":"Cass, A. S. & Ireland, G. W. Antibacterial perineal washing for prevention of recurrent urinary tract infections. Urology 25, 492\u2013494 (1985).","journal-title":"Urology"},{"key":"64291_CR5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/00001648-200207000-00011","volume":"13","author":"MA Handley","year":"2002","unstructured":"Handley, M. A., Reingold, A. L., Shiboski, S. & Padian, N. S. Incidence of acute urinary tract infection in young women and use of male condoms with and without nonoxynol-9 spermicides. Epidemiology 13, 431\u2013436 (2002).","journal-title":"Epidemiology"},{"key":"64291_CR6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nrurol.2010.101","volume":"7","author":"GR Nielubowicz","year":"2010","unstructured":"Nielubowicz, G. R. & Mobley, H. L. T. Host\u2013pathogen interactions in urinary tract infection. Nature Reviews Urology 7, 430 (2010).","journal-title":"Nature Reviews Urology"},{"key":"64291_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1113\/JP271694","volume":"595","author":"SB Smith","year":"2017","unstructured":"Smith, S. B. & Ravel, J. The vaginal microbiota, host defence and reproductive physiology. The Journal of physiology 595, 451\u2013463 (2017).","journal-title":"The Journal of physiology"},{"key":"64291_CR8","doi-asserted-by":"crossref","unstructured":"Stapleton, A.E. The Vaginal Microbiota and Urinary Tract Infection. Microbiology spectrum 4 (2016).","DOI":"10.1128\/microbiolspec.UTI-0025-2016"},{"key":"64291_CR9","first-page":"331","volume":"89","author":"KL Nunn","year":"2016","unstructured":"Nunn, K. L. & Forney, L. J. Unraveling the Dynamics of the Human Vaginal Microbiome. The Yale journal of biology and medicine 89, 331\u2013337 (2016).","journal-title":"The Yale journal of biology and medicine"},{"key":"64291_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/09513590.2017.1407753","volume":"34","author":"K Godha","year":"2018","unstructured":"Godha, K., Tucker, K. M., Biehl, C., Archer, D. F. & Mirkin, S. Human vaginal pH and microbiota: an update. Gynecol Endocrinol 34, 451\u2013455 (2018).","journal-title":"Gynecol Endocrinol"},{"key":"64291_CR11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1574-6976.2012.00339.x","volume":"36","author":"TJ Hannan","year":"2012","unstructured":"Hannan, T. J. et al. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS microbiology reviews 36, 616\u2013648 (2012).","journal-title":"FEMS microbiology reviews"},{"key":"64291_CR12","doi-asserted-by":"crossref","unstructured":"De Nisco, N. J. et al. Direct Detection of Tissue-Resident Bacteria and Chronic Inflammation in the Bladder Wall of Postmenopausal Women with Recurrent Urinary Tract Infection. J Mol Biol (2019).","DOI":"10.1016\/j.jmb.2019.04.008"},{"key":"64291_CR13","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/j.juro.2013.04.142","volume":"190","author":"MA Beerepoot","year":"2013","unstructured":"Beerepoot, M. A., Geerlings, S. E., van Haarst, E. P., van Charante, N. M. & ter Riet, G. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. The Journal of urology 190, 1981\u20131989 (2013).","journal-title":"The Journal of urology"},{"key":"64291_CR14","doi-asserted-by":"crossref","unstructured":"Tamadonfar, K. O., Omattage, N. S., Spaulding, C. N. & Hultgren, S. J. Reaching the End of the Line: Urinary Tract Infections. Microbiology spectrum 7 (2019).","DOI":"10.1128\/microbiolspec.BAI-0014-2019"},{"key":"64291_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.maturitas.2016.05.015","volume":"91","author":"AL Muhleisen","year":"2016","unstructured":"Muhleisen, A. L. & Herbst-Kralovetz, M. M. Menopause and the vaginal microbiome. Maturitas 91, 42\u201350 (2016).","journal-title":"Maturitas"},{"key":"64291_CR16","doi-asserted-by":"publisher","first-page":"190ra180","DOI":"10.1126\/scitranslmed.3005574","volume":"5","author":"P Luthje","year":"2013","unstructured":"Luthje, P. et al. Estrogen supports urothelial defense mechanisms. Science translational medicine 5, 190ra180 (2013).","journal-title":"Science translational medicine"},{"key":"64291_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10445-4","volume":"7","author":"ASM Ali","year":"2017","unstructured":"Ali, A. S. M. et al. Targeting Deficiencies in the TLR5 Mediated Vaginal Response to Treat Female Recurrent Urinary Tract Infection. Scientific reports 7, 11039 (2017).","journal-title":"Scientific reports"},{"key":"64291_CR18","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.maturitas.2007.09.009","volume":"58","author":"MM Cotreau","year":"2007","unstructured":"Cotreau, M. M. et al. A study of 17beta-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy. Maturitas 58, 366\u2013376 (2007).","journal-title":"Maturitas"},{"key":"64291_CR19","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1111\/jcmm.14199","volume":"23","author":"T Tyagi","year":"2019","unstructured":"Tyagi, T., Alarab, M., Leong, Y., Lye, S. & Shynlova, O. Local oestrogen therapy modulates extracellular matrix and immune response in the vaginal tissue of post-menopausal women with severe pelvic organ prolapse. J Cell Mol Med 23, 2907\u20132919 (2019).","journal-title":"J Cell Mol Med"},{"key":"64291_CR20","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","volume":"24","author":"P Du","year":"2008","unstructured":"Du, P., Kibbe, W. A. & Lin, S. M. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24, 1547\u20131548 (2008).","journal-title":"Bioinformatics"},{"key":"64291_CR21","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43, e47 (2015).","journal-title":"Nucleic Acids Res"},{"key":"64291_CR22","doi-asserted-by":"publisher","first-page":"e1021","DOI":"10.1002\/cti2.1021","volume":"7","author":"CA Mowbray","year":"2018","unstructured":"Mowbray, C. A. et al. High molecular weight hyaluronic acid: a two-pronged protectant against infection of the urogenital tract? Clinical & translational immunology 7, e1021 (2018).","journal-title":"Clinical & translational immunology"},{"key":"64291_CR23","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.4049\/jimmunol.178.8.4717","volume":"178","author":"E Andersen-Nissen","year":"2007","unstructured":"Andersen-Nissen, E. et al. Cutting edge: Tlr5-\/- mice are more susceptible to Escherichia coli urinary tract infection. Journal of immunology 178, 4717\u20134720 (2007).","journal-title":"Journal of immunology"},{"key":"64291_CR24","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1210\/en.2012-1061","volume":"153","author":"EJ Filardo","year":"2012","unstructured":"Filardo, E. J. & Thomas, P. Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. Endocrinology 153, 2953\u20132962 (2012).","journal-title":"Endocrinology"},{"key":"64291_CR25","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/ni.3742","volume":"18","author":"M Veldhoen","year":"2017","unstructured":"Veldhoen, M. Interleukin 17 is a chief orchestrator of immunity. Nature immunology 18, 612\u2013621 (2017).","journal-title":"Nature immunology"},{"key":"64291_CR26","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/GME.0b013e3182a4690b","volume":"21","author":"RM Brotman","year":"2014","unstructured":"Brotman, R. M. et al. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause 21, 450\u2013458 (2014).","journal-title":"Menopause"},{"key":"64291_CR27","doi-asserted-by":"publisher","first-page":"16669","DOI":"10.1073\/pnas.0607898104","volume":"104","author":"MC Lane","year":"2007","unstructured":"Lane, M. C., Alteri, C. J., Smith, S. N. & Mobley, H. L. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proceedings of the National Academy of Sciences of the United States of America 104, 16669\u201316674 (2007).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"64291_CR28","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.juro.2011.04.112","volume":"186","author":"NJ Smith","year":"2011","unstructured":"Smith, N. J. et al. Toll-like receptor responses of normal human urothelial cells to bacterial flagellin and lipopolysaccharide. The Journal of urology 186, 1084\u20131092 (2011).","journal-title":"The Journal of urology"},{"key":"64291_CR29","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/humrep\/deh775","volume":"20","author":"A Fazeli","year":"2005","unstructured":"Fazeli, A., Bruce, C. & Anumba, D. O. Characterization of Toll-like receptors in the female reproductive tract in humans. Hum Reprod 20, 1372\u20131378 (2005).","journal-title":"Hum Reprod"},{"key":"64291_CR30","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1600-0897.2007.00566.x","volume":"59","author":"MM Herbst-Kralovetz","year":"2008","unstructured":"Herbst-Kralovetz, M. M. et al. Quantification and comparison of toll-like receptor expression and responsiveness in primary and immortalized human female lower genital tract epithelia. Am J Reprod Immunol 59, 212\u2013224 (2008).","journal-title":"Am J Reprod Immunol"},{"key":"64291_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.cyto.2009.09.005","volume":"49","author":"JH Han","year":"2010","unstructured":"Han, J. H. et al. Modulation of human beta-defensin-2 expression by 17beta-estradiol and progesterone in vaginal epithelial cells. Cytokine 49, 209\u2013214 (2010).","journal-title":"Cytokine"},{"key":"64291_CR32","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1095\/biolreprod59.3.470","volume":"59","author":"PS Cooke","year":"1998","unstructured":"Cooke, P. S., Buchanan, D. L., Lubahn, D. B. & Cunha, G. R. Mechanism of estrogen action: lessons from the estrogen receptor-alpha knockout mouse. Biology of reproduction 59, 470\u2013475 (1998).","journal-title":"Biology of reproduction"},{"key":"64291_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/aji.12078","volume":"69","author":"MV Patel","year":"2013","unstructured":"Patel, M. V., Fahey, J. V., Rossoll, R. M. & Wira, C. R. Innate immunity in the vagina (part I): estradiol inhibits HBD2 and elafin secretion by human vaginal epithelial cells. Am J Reprod Immunol 69, 463\u2013474 (2013).","journal-title":"Am J Reprod Immunol"},{"key":"64291_CR34","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/humupd\/dmu065","volume":"21","author":"VL Yarbrough","year":"2015","unstructured":"Yarbrough, V. L., Winkle, S. & Herbst-Kralovetz, M. M. Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications. Hum Reprod Update 21, 353\u2013377 (2015).","journal-title":"Hum Reprod Update"},{"key":"64291_CR35","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1177\/1933719116667489","volume":"24","author":"CE Foust-Wright","year":"2017","unstructured":"Foust-Wright, C. E. et al. Hormone Modulation of Toll-Like Receptor 5 in Cultured Human Bladder Epithelial Cells. Reproductive sciences 24, 713\u2013719 (2017).","journal-title":"Reproductive sciences"},{"key":"64291_CR36","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1172\/JCI64416","volume":"122","author":"C Tam","year":"2012","unstructured":"Tam, C., Mun, J. J., Evans, D. J. & Fleiszig, S. M. Cytokeratins mediate epithelial innate defense through their antimicrobial properties. The Journal of clinical investigation 122, 3665\u20133677 (2012).","journal-title":"The Journal of clinical investigation"},{"key":"64291_CR37","doi-asserted-by":"publisher","first-page":"L6","DOI":"10.1152\/ajplung.00344.2017","volume":"314","author":"SJ Gurczynski","year":"2018","unstructured":"Gurczynski, S. J. & Moore, B. B. IL-17 in the lung: the good, the bad, and the ugly. Am J Physiol Lung Cell Mol Physiol 314, L6\u2013L16 (2018).","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"64291_CR38","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3389\/fimmu.2018.00796","volume":"9","author":"DR McKenzie","year":"2018","unstructured":"McKenzie, D. R., Comerford, I., Silva-Santos, B. & McColl, S. R. The Emerging Complexity of gammadeltaT17 Cells. Front Immunol 9, 796 (2018).","journal-title":"Front Immunol"},{"key":"64291_CR39","doi-asserted-by":"publisher","first-page":"e22770","DOI":"10.1371\/journal.pone.0022770","volume":"6","author":"D Pietrella","year":"2011","unstructured":"Pietrella, D. et al. Th17 cells and IL-17 in protective immunity to vaginal candidiasis. PloS one 6, e22770 (2011).","journal-title":"PloS one"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64291-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64291-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64291-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T11:39:19Z","timestamp":1670326759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64291-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["64291"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-64291-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,21]]},"assertion":[{"value":"19 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8473"}}